Characterization of Survival Outcomes and Clinical and Molecular Modulators in Adult Patients with Core-Binding Factor Acute Myeloid Leukemia (CBF-AML): An Alliance Legacy Study
- Citation:
- Blood vol 140 (suppl 1) 1284–5
- Meeting Instance:
- ASH 2022
- Year:
- 2022
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Leuk Corr Sci
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171
- Corr. Author:
- Authors:
- Jonathon Hyak Deedra Nicolet Jessica Kohlschmidt Kellie J. Archer James S. Blachly Bayard L. Powell Jonathan E. Kolitz Maria R. Baer William G. Blum Geoffrey Uy Wendy Stock John C. Byrd Krzysztof Mrózek Ann-Kathrin Eisfeld Alice S. Mims
- Networks:
- LAPS-IL057, LAPS-MO011, LAPS-OH007, MD015, NC002, NORTHWELL, OH070
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-20202, CALGB-8461, CALGB-9665
- Phases:
- N/A
- Keywords: